Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab

Conclusions
Eculizumab therapy during pregnancy displayed no overt safety issues but did not appear to prevent HELLP syndrome or pre-eclampsia in these high-risk chronic kidney disease patients.

Source: Nephrology Dialysis Transplantation - December 7, 2016 Category: Urology & Nephrology Authors: Servais, A., Devillard, N., Fremeaux-Bacchi, V., Hummel, A., Salomon, L., Contin-Bordes, C., Gomer, H., Legendre, C., Delmas, Y. Tags: Intra- and Extracorporeal Treatments of Kidney Failure Source Type: research